Abstract
With the increasing availability and adoption of genetic testing in cardiovascular disease (CVD), effective post-testing management is becoming crucial for optimizing patient outcomes and providing personalized care. This chapter focuses on key strategies and considerations for interpreting genetic test results in CVD, navigating complex scenarios such as incidental findings (IFs) and variants of unknown significance (VUS), and utilizing advanced tools and databases for evidence-based interpretation. As genetic testing becomes more integrated into routine clinical practice, the ability to communicate results clearly and accurately to patients and their families is paramount. This chapter provides practical guidance on delivering genetic information in a clinically meaningful way while adhering to international recommendations and addressing sensitive issues like non-paternity disclosure and risk assessment for family members through cascade testing. Special attention is given to the unique challenges of testing minors and the ethical frameworks that guide these decisions. Finally, the chapter addresses the psychosocial implications of CVD genetic testing and offers support strategies to help patients and families navigate the impact of their results. As the field of CVD genetics continues to expand, this comprehensive approach is essential for translating genetic data into actionable insights that enhance patient care and family health management.

This publication has 54 references indexed in Scilit: